Cancer vaccine against brain tumours tested in patients for the first time – The European Scientist

Researchers and doctors from several centres across Germany, including the German Cancer Research Center, and the National Center for Tumor Diseases (NCT), carried out the first clinical trial to test a new vaccine against malignant brain tumours, according to a study published in the journal Nature (1). The results were very promising. Not only the vaccine was safe for all patients, but it also started the desired immune response in the cancerous tissue.
Vaccines against cancer are not a new idea….

Click here to view the original article.